Adaptive Biotechnologies ADPT
$27.93 −$0.12 (-0.43%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.89 -0.14%
Open$27.43
Prev close$28.05
Day range$27.15 – $28.23
Volume2.48M
Market cap$4.52B
P/E (TTM)–
Dividend yield–
ADPT Stock News
Headlines matching Adaptive Biotechnologies or the ADPT ticker, most recent first.
- Goldman Sachs Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $35
- BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $34
- BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $34 Positive
- Adaptive Biotechnologies(ADPT.US) Officer Sells US$3.24 Million in Common Stock
- Craig-Hallum Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating
- Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $27.5 Positive
- Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $27.5
- A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $25 to $28
- BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $24 Positive
- TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $25 Positive
- Guggenheim Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $22 Positive
- William Blair Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating
- A Quick Look at Today's Ratings for Adaptive Biotechnologies(ADPT.US), With a Forecast Between $19 to $22
- Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Cuts Target Price to $13.54 Negative
- Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $20
No comments yet — be the first to weigh in on ADPT.
Sign in to join the discussion.